Incendia Therapeutics

Incendia Therapeutics President & CEO Wendye Robbins is featured in GBHNews' new Women in Biotech series. Hear her perspective on leadership and empowering women in biotech. https://lnkd.in/eDisnDNF

Incendia Therapeutics is excited to announce the appointment of Dr. Louis Lange to our Board of Directors. Dr. Lange, a General Partner with Asset Management Ventures, Inc., is a highly successful biotechnology investor and serial entrepreneur with deep experience building companies that have generated scientific breakthroughs and significant value for patients and investors.    For more details, click on the news release link at https://lnkd.in/eNFmEKrA. #tumormicroenvironment #cancer #biotech #innovation #Boardofdirectors

Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer https://lnkd.in/gnr2tAsD Your go-to for local business news. Follow citybiz Incendia Therapeutics #biotechnology #chieffinanicalofficer

Please join Incendia Therapeutics in welcoming Brad Smith as our Chief Financial Officer (https://lnkd.in/ePr9wfXb). Brad is an accomplished financial executive with more than 30 years of strategic and operational leadership in emerging growth and commercial stage healthcare companies, including experience in private and public equity financings with more than $1 billion raised.    For more details, click on the news release link or visit the “News” page of Incendia's website (www.incendiatx.com).    #tumormicroenvironment #cancer #biotech #innovation #CFO Brad Smith Wendye Robbins

Celebrating Thanksgiving with a potluck lunch at Incendia Therapeutics! Delicious dishes were prepared and enjoyed by everyone. Support, collaboration and team spirit have made this event truly special. Here is to continued success, health and happiness.

Incendia Therapeutics presented three posters at the 39th annual meeting of the Society for Immunotherapy of Cancer (SITC) in Houston. Congratulations to our research partners and team members who led this research illustrating the important role of the tumor microenvironment in solid cancers. To download the posters, visit the “Presentations and Publications” page of Incendia’s website (www.incendiatx.com) or click on the links provided next to the poster titles below. Exclusion of CD8 T Cells from Tumor Epithelium is Associated with Worse Immune Checkpoint Blockade (ICB) Therapy Response and Survival in Non-Small Cell Lung Cancer (NSCLC) https://lnkd.in/etekc6Nn Spatial transcriptomics analysis reveals association between DDR1-collagen interactions and immune exclusion in human cancers https://lnkd.in/ef-eud99 Stromal collagen features from H&E-stained whole slide images are associated with lymphocyte infiltration and survival following checkpoint inhibition in patients with non-small cell lung cancer https://lnkd.in/eWCuabYW #cancer #immunotherapy #biotech #innovation #SITC2024

Incendia Therapeutics is proud to announce the presentation of new clinical data from a Phase 1 study of PRTH-101 at the International Thymic Malignancy Interest Group Annual Meeting 2024 in Yokohama, Japan. To download a PDF of the poster, scan the QR code within this posting or visit the “Presentations and Publications” page of Incendia’s website. https://lnkd.in/eU_hDuWb Thank you to the investigators, patients and their families for their participation in this trial. Susan Macdonald Thomas Schürpf #cancer #thymiccancer #biotech #innovation #ITMIG

Terrific discussion on lessons learned and surprises manged in #biotech company formation w/ Atavistik Bio Entrada Therapeutics Mural Oncology Incendia Therapeutics & Progentos

Incendia Therapeutics CEO Wendye Robbins will join esteemed industry leaders in a panel discussion addressing “Company Formation: Building a Biotech" at Boston CEO on Monday, October 28th. Learn more at Longwood Healthcare Leaders. #longwoodhealthcareleaders #BostonCEO #biotech #innovation

Fanning the flames of innovation keeps the engines running in the life science industry. Incendia CEO Wendye Robbins helped stoke her colleagues’ passion by participating in the Alumni Panel during today’s JLABS Global CEO Summit at the New York Stock Exchange. #innovation #biotech #research